SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Breen N, Cronin KA, Meissner HI, et al. Reported drop in mammography: is this cause for concern? Cancer. 2007; 109: 2405-2409.
  • 2
    Fletcher SW. Whither scientific deliberation in health policy recommendations? Alice in the Wonderland of breast-cancer screening. N Engl J Med. 1997; 336: 1180-1183.
  • 3
    Miller AB. Is routine mammography screening appropriate for women 40-49 years of age? Am J Prev Med. 1991; 7: 55-62.
  • 4
    Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst. 1993; 85: 1644-1656.
  • 5
    Hendrick RE, Smith RA, Rutledge JH III, Smart C.R. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr. 1997;( 22): 87-92.
  • 6
    Smigel K. NCI's proposed breast cancer screening guidelines. J Natl Cancer Inst. 1993; 85: 1627-1627.
  • 7
    U.S. Preventive Services Task Force. U.S. Preventive Services Task Force: Screening for Breast Cancer. Washington, DC: Agency for Healthcare and Research Quality; 2009. http://www.ahrq.gov/clinic/USpstf/uspsbrca.htm. Accessed January 21, 2010.
  • 8
    Kerlikowske K. Evidence-based breast cancer prevention: the importance of individual risk. Ann Intern Med. 2009; 151: 750-752.
  • 9
    Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009; 151: 727-742.
  • 10
    Mandelblatt J, Saha S, Teutsch S, et al. The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2003; 139: 835-842.
  • 11
    Schenker N, Raghunathan TE, Chiu PL, Makuc DM, Zhang G, Cohen AJ. Multiple imputation of missing income data in the National Health Interview Survey. J Am Stat Assoc. 2006; 101: 924-933.
  • 12
    Berry DA. Benefits and risks of screening mammography for women in their forties: a statistical appraisal. J Natl Cancer Inst. 1998; 90: 1431-1439.
  • 13
    Elmore J, Choe J. Breast cancer screening for women in their 40s: moving from controversy about data to helping individual women. Ann Intern Med. 2007; 146: 529-531.
  • 14
    Kolata G. Stand on mammograms greeted by outrage. New York Times. January 28, 1997: C1.
  • 15
    Winger P. The myth of the mammogram: why many women are resolutely rejecting the new mammogram recommendations, despite mixed reaction in the medical community. Newsweek. November 20, 2009.
  • 16
    Klabunde CN, Riley GF, Mandelson MT, Frame PS, Brown ML. Health plan policies and programs for colorectal cancer screening: a national profile. Am J Manag Care. 2004; 10: 273-279.
  • 17
    Makuc DM, Freid VM, Parsons PE. Health Insurance and Cancer Screening Among Women. Advance Data From Vital and Health Statistics of the Centers for Disease Control and Prevention, No. 254. Hyattsville, MD: National Center for Health Statistics; 1994.
  • 18
    Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334-357.
  • 19
    Breen N, Feuer EJ, Depuy S, Zapka JG. The effect of Medicare reimbursement for screening mammography on utilization and payment. Public Health Rep. 1997; 112: 423-432.
  • 20
    Rogers EM, Shoemaker FF. Communication of Innovations. New York: The Free Press; 1971.
  • 21
    Breen N, Kessler L. Changes in the use of screening mammography: evidence from the 1987 and 1990 National Health Interview Surveys. Am J Public Health. 1994; 84: 62-67.
  • 22
    Borrayo EA, Hines L, Byers T, et al. Characteristics associated with mammography screening among both Hispanic and non-Hispanic white women. J Womens Health (Larchmt). 2009; 18: 1585-1594.
  • 23
    Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004; 291: 47-53.
  • 24
    Buist DS, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol. 2004; 104: 1042-1050.
  • 25
    Taplin SH, Ichikawa L, Yood MU, et al. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst. 2004; 96: 1518-1527.
  • 26
    Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009; 151: 738-747.